Robert Orenstein

InstitutionDivision of Infectious Diseases
AddressPhoenix
Arizona
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 2 publications in June 2021
    All Publications
    Bar chart showing 58 publications over 19 distinct years, with a maximum of 6 publications in 2016
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ganesh R, Pawlowski CF, O'Horo JC, Arndt LL, Arndt RF, Bell SJ, Bierle DM, Borgen MD, Hanson SN, Heyliger A, Larsen JJ, Lenehan PJ, Orenstein R, Puranik A, Speicher LL, Tulledge-Scheitel SM, Venkatakrishnan AJ, Wilker CG, Badley AD, Razonable RR. Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19. J Clin Invest. 2021 10 01; 131(19). PMID: 34411003.
      Citations: 2     Fields:    Translation:Humans
    2. Coffey JD, Christopherson LA, Glasgow AE, Pearson KK, Brown JK, Gathje SR, Sangaralingham LR, Carmona Porquera EM, Virk A, Orenstein R, Speicher LL, Bierle DM, Ganesh R, Cox DL, Blegen RN, Haddad TC. Implementation of a multisite, interdisciplinary remote patient monitoring program for ambulatory management of patients with COVID-19. NPJ Digit Med. 2021 Aug 13; 4(1):123. PMID: 34389787.
      Citations: 6     
    3. Blair JE, Gotimukul A, Wang F, Mina SA, Bartels HC, Burns MW, Kole AE, Vikram HR, Gea-Banacloche JC, Seville MT, Petty SAB, Vikram A, Orenstein R. Mild to moderate COVID-19 illness in adult outpatients: Characteristics, symptoms, and outcomes in the first 4 weeks of illness. Medicine (Baltimore). 2021 Jun 18; 100(24):e26371. PMID: 34128896.
      Citations: 1     Fields:    Translation:Humans
    4. Pritchett JC, Borah BJ, Desai AP, Xie Z, Saliba AN, Leventakos K, Coffey JD, Pearson KK, Speicher LL, Orenstein R, Virk A, Ganesh R, Paludo J, Halfdanarson TR, Haddad TC. Association of a Remote Patient Monitoring (RPM) Program With Reduced Hospitalizations in Cancer Patients With COVID-19. JCO Oncol Pract. 2021 09; 17(9):e1293-e1302. PMID: 34085535.
      Citations: 1     Translation:Humans
    5. Razonable RR, Aloia NCE, Anderson RJ, Anil G, Arndt LL, Arndt RF, Ausman SE, Bell SJ, Bierle DM, Billings ML, Bishop RK, Cramer CH, Culbertson TL, Dababneh AS, Derr AN, Epps K, Flaker SM, Ganesh R, Gilmer MA, Urena EG, Gulden CR, Haack TL, Hanson SN, Herzog JR, Heyliger A, Hokanson LD, Hopkins LH, Horecki RJ, Krishna BH, Huskins WC, Jackson TA, Johnson RR, Jorgenson B, Kudrna C, Kennedy BD, Klingsporn MK, Kottke B, Larsen JJ, Lessard SR, Lutwick LI, Malone EJ, Matoush JA, Micallef IN, Moehnke DE, Mohamed M, Ness CN, Olson SM, Orenstein R, Palraj R, Patel J, Paulson DJ, Phelan D, Peinovich MT, Ramsey WL, Rau-Kane TJ, Reid KI, Reinschmidt KJ, Seville MT, Skold EC, Smith JM, Speicher LL, Spielman LA, et al. A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model. Mayo Clin Proc. 2021 05; 96(5):1250-1261. PMID: 33958056.
      Citations: 6     Fields:    Translation:Humans
    6. O'Horo JC, Cerhan JR, Cahn EJ, Bauer PR, Temesgen Z, Ebbert J, Abril A, Abu Saleh OM, Assi M, Berbari EF, Bierle DM, Bosch W, Burger CD, Cano Cevallos EJ, Clements CM, Carmona Porquera EM, Castillo Almeida NE, Challener DW, Chesdachai S, Comba IY, Corsini Campioli CG, Crane SJ, Dababneh AS, Enzler MJ, Fadel HJ, Ganesh R, De Moraes AG, Go JR, Gordon JE, Gurram PR, Guru PK, Halverson EL, Harrison MF, Heaton HA, Hurt R, Kasten MJ, Lee AS, Levy ER, Libertin CR, Mallea JM, Marshall WF, Matcha G, Meehan AM, Franco PM, Morice WG, O'Brien JJ, Oeckler R, Ommen S, Oravec CP, Orenstein R, Ough NJ, Palraj R, Patel BM, Pureza VS, Pickering B, Phelan DM, Razonable RR, Rizza S, Sampathkumar P, Sanghavi DK, Sen A, Siegel JL, Singbartl K, et al. Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo Clin Proc. 2021 03; 96(3):601-618. PMID: 33673913.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    7. Temesgen Z, Assi M, Shweta FNU, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Palraj R, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley AD. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 11; 95(11):2382-2394. PMID: 33153629.
      Citations: 34     Fields:    Translation:HumansPHPublic Health
    8. Burger CD, Mikhail AE, Orenstein R, Ebbert JO, Vergidis P, Badley AD. Research Response to SARS-CoV-2/COVID-19. Mayo Clin Proc. 2020 09; 95(9S):S52-S55. PMID: 32807524.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    9. Valencia-Sanchez C, Steenerson KK, Kelemen K, Orenstein R, Kusne S, Grill MF. Post-transplant primary central nervous system lymphoma after Epstein-Barr virus cerebellitis. J Neurovirol. 2019 04; 25(2):280-283. PMID: 30607891.
      Citations:    Fields:    Translation:HumansCells
    10. Dubberke ER, Lee CH, Orenstein R, Khanna S, Hecht G, Gerding DN. Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection. Clin Infect Dis. 2018 09 28; 67(8):1198-1204. PMID: 29617739.
      Citations: 20     Fields:    Translation:HumansCellsCTClinical Trials
    11. Tariq R, Cho J, Kapoor S, Orenstein R, Singh S, Pardi DS, Khanna S. Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis. Clin Infect Dis. 2018 02 01; 66(4):514-522. PMID: 29401273.
      Citations: 14     Fields:    Translation:HumansCells
    12. Orenstein R, King K, Patron RL, DiBaise JK, Etzioni D. Mini-Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis Following Total Colectomy. Clin Infect Dis. 2018 01 06; 66(2):299-300. PMID: 29020255.
      Citations:    Fields:    Translation:Humans
    13. Patron RL, Hartmann CA, Allen S, Griesbach CL, Kosiorek HE, DiBaise JK, Orenstein R. Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection. Clin Infect Dis. 2017 10 01; 65(7):1214-1217. PMID: 28575220.
      Citations: 5     Fields:    Translation:HumansCells
    14. Orenstein R. History of Osteopathic Medicine: Still Relevant? J Am Osteopath Assoc. 2017 03 01; 117(3):148. PMID: 28241324.
      Citations:    Fields:    Translation:Humans
    15. Orenstein R. Antimicrobial Stewardship and Osteopathic Medicine: A Call to Action. J Am Osteopath Assoc. 2016 09 01; 116(9):564-6. PMID: 27571291.
      Citations:    Fields:    Translation:Humans
    16. Fitterer C, Berg Z, Halfdanarson TR, Vikram HR, Kusne S, Orenstein R, Seville MT, Blair JE. Coccidioidomycosis in Patients with Selected Solid Organ Cancers: A Case Series and Review of Medical Literature. Mycopathologia. 2016 Dec; 181(11-12):787-798. PMID: 27492230.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    17. Scotch AH, Hoss E, Orenstein R, Budavari AI. Disseminated Varicella-Zoster Virus After Vaccination in an Immunocompetent Patient. J Am Osteopath Assoc. 2016 Jun 01; 116(6):402-5. PMID: 27214778.
      Citations: 2     Fields:    Translation:HumansCells
    18. Orenstein R. ENGAGE Initiative: Showcasing Osteopathic Scholarly Activity. J Am Osteopath Assoc. 2016 May 01; 116(5):276-7. PMID: 27111776.
      Citations: 1     Fields:    
    19. Leekha S, Lahr BD, Thompson RL, Sampathkumar P, Duncan AA, Orenstein R. Preoperative risk prediction of surgical site infection requiring hospitalization or reoperation in patients undergoing vascular surgery. J Vasc Surg. 2016 07; 64(1):177-84. PMID: 26926939.
      Citations: 2     Fields:    Translation:Humans
    20. Seto CT, Jeraldo P, Orenstein R, Chia N, DiBaise JK. Erratum to: Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome. 2016 Feb 22; 4:10. PMID: 26905900.
      Citations:    Fields:    
    21. Orenstein R, Dubberke E, Hardi R, Ray A, Mullane K, Pardi DS, Ramesh MS. Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study. Clin Infect Dis. 2016 Mar 01; 62(5):596-602. PMID: 26565008.
      Citations: 33     Fields:    Translation:HumansCellsCTClinical Trials
    22. Campbell M, Kusne S, Renfree KJ, Vikram HR, Smilack JD, Seville MT, Orenstein R, Blair JE. Coccidioidal Tenosynovitis of the Hand and Wrist: Report of 9 Cases and Review of the Literature. Clin Infect Dis. 2015 Nov 15; 61(10):1514-20. PMID: 26240199.
      Citations: 2     Fields:    Translation:HumansAnimals
    23. Seto CT, Jeraldo P, Orenstein R, Chia N, DiBaise JK. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome. 2014; 2:42. PMID: 25426290.
      Citations: 55     Fields:    
    24. Orenstein R. Emerging infections: the cauldron of medicine, mobility, and media. J Am Osteopath Assoc. 2014 Nov; 114(11):e122-3. PMID: 25352413.
      Citations:    Fields:    Translation:HumansPHPublic Health
    25. Blair JE, Chang YH, Cheng MR, Vaszar LT, Vikram HR, Orenstein R, Kusne S, Ho S, Seville MT, Parish JM. Characteristics of patients with mild to moderate primary pulmonary coccidioidomycosis. Emerg Infect Dis. 2014 Jun; 20(6):983-90. PMID: 24865953.
      Citations: 17     Fields:    Translation:HumansAnimals
    26. Orenstein R. The Journal of the American Osteopathic Association: the next generation. J Am Osteopath Assoc. 2014 May; 114(5):332-3. PMID: 24777994.
      Citations:    Fields:    Translation:Humans
    27. Orenstein R, Griesbach CL, DiBaise JK. Moving fecal microbiota transplantation into the mainstream. Nutr Clin Pract. 2013 Oct; 28(5):589-98. PMID: 23979974.
      Citations: 1     Fields:    Translation:HumansCells
    28. Patel NC, Griesbach CL, DiBaise JK, Orenstein R. Fecal microbiota transplant for recurrent Clostridium difficile infection: Mayo Clinic in Arizona experience. Mayo Clin Proc. 2013 Aug; 88(8):799-805. PMID: 23910407.
      Citations: 15     Fields:    Translation:HumansCells
    29. Leekha S, Aronhalt KC, Sloan LM, Patel R, Orenstein R. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. Am J Infect Control. 2013 May; 41(5):390-3. PMID: 23622704.
      Citations: 27     Fields:    Translation:HumansCells
    30. Azadeh N, Chang YH, Kusne S, Vikram HR, Seville MT, Orenstein R, Blair JE. The impact of early and brief corticosteroids on the clinical course of primary pulmonary coccidioidomycosis. J Infect. 2013 Aug; 67(2):148-55. PMID: 23570823.
      Citations: 1     Fields:    Translation:Humans
    31. Virk A, Mandrekar J, Berbari EF, Boyce TG, Fischer PR, Kasten MJ, Orenstein R, Rosenblatt JE, Sampathkumar P, Sia I, Springer D, Witzig TE. A randomized, double blind, placebo-controlled trial of an oral synbiotic (AKSB) for prevention of travelers' diarrhea. J Travel Med. 2013 Mar-Apr; 20(2):88-94. PMID: 23464715.
      Citations: 3     Fields:    Translation:Humans
    32. Bongartz T, Orenstein R. Immunology: Zoster vaccine and biologic agents: time to question a paradigm? Nat Rev Rheumatol. 2012 Nov; 8(11):636-8. PMID: 23027029.
      Citations:    Fields:    Translation:Humans
    33. Orenstein R. Fidaxomicin failures in recurrent Clostridium difficile infection: a problem of timing. Clin Infect Dis. 2012 Aug; 55(4):613-4. PMID: 22610922.
      Citations: 10     Fields:    Translation:HumansCells
    34. Aronhalt KC, McManus J, Orenstein R, Faller R, Link M. Patient and environmental service employee satisfaction of using germicidal bleach wipes for patient room cleaning. J Healthc Qual. 2013 Nov-Dec; 35(6):30-6. PMID: 22530592.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    35. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, Harmsen WS, Zinsmeister AR. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012 Jan; 107(1):89-95. PMID: 22108454.
      Citations: 202     Fields:    Translation:Humans
    36. Orenstein R, Aronhalt KC, McManus JE, Fedraw LA. A targeted strategy to wipe out Clostridium difficile. Infect Control Hosp Epidemiol. 2011 Nov; 32(11):1137-9. PMID: 22011546.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic Health
    37. Olson TC, Bongartz T, Crowson CS, Roberts GD, Orenstein R, Matteson EL. Histoplasmosis infection in patients with rheumatoid arthritis, 1998-2009. BMC Infect Dis. 2011 May 23; 11:145. PMID: 21605439.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    38. Kamal A, Orenstein R. Disseminated sporotrichosis. J Hosp Med. 2010 Mar; 5(3):E29-30. PMID: 20235306.
      Citations:    Fields:    Translation:Humans
    39. Orenstein R, Litin SC. Clinical pearls in infectious diseases. Mayo Clin Proc. 2010 Feb; 85(2):172-5. PMID: 20118393.
      Citations:    Fields:    Translation:HumansCells
    40. Lachance DH, Lennon VA, Pittock SJ, Tracy JA, Krecke KN, Amrami KK, Poeschla EM, Orenstein R, Scheithauer BW, Sejvar JJ, Holzbauer S, Devries AS, Dyck PJ. An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study. Lancet Neurol. 2010 Jan; 9(1):55-66. PMID: 19945916.
      Citations: 19     Fields:    Translation:HumansAnimalsPHPublic Health
    41. Verdoorn BP, Orenstein R, Rosenblatt JE, Sloan LM, Schleck CD, Harmsen WS, Nyre LM, Patel R. High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity. Diagn Microbiol Infect Dis. 2010 Jan; 66(1):24-8. PMID: 19775847.
      Citations: 16     Fields:    Translation:HumansCells
    42. Drage LA, Ecker PM, Orenstein R, Phillips PK, Edson RS. An outbreak of Mycobacterium chelonae infections in tattoos. J Am Acad Dermatol. 2010 Mar; 62(3):501-6. PMID: 19733936.
      Citations: 14     Fields:    Translation:HumansCellsPHPublic Health
    43. Bongartz T, Orenstein R. Therapy: The risk of herpes zoster: another cost of anti-TNF therapy? Nat Rev Rheumatol. 2009 Jul; 5(7):361-3. PMID: 19568250.
      Citations: 5     Fields:    Translation:Humans
    44. Verdoorn BP, Orenstein R, Wilson JW, Estes LL, Wendt RF, Schleck CD, Harmsen WS, Nyre LM, Patel R. Effect of telephoned notification of positive Clostridium difficile test results on the time to the ordering of antimicrobial therapy. Infect Control Hosp Epidemiol. 2008 Jul; 29(7):658-60. PMID: 18518668.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    45. Toruner M, Loftus EV, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, Colombel JF, Egan LJ. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology. 2008 Apr; 134(4):929-36. PMID: 18294633.
      Citations: 248     Fields:    Translation:Humans
    46. Mauermann ML, Klein CJ, Orenstein R, Dyck PJ. Disseminated sporotrichosis presenting with granulomatous inflammatory multiple mononeuropathies. Muscle Nerve. 2007 Dec; 36(6):866-72. PMID: 17623855.
      Citations: 2     Fields:    Translation:HumansAnimals
    47. Orenstein R. Study on recurrent otitis media: potential value vs actual value of OMT. J Am Osteopath Assoc. 2007 Jul; 107(7):278-9. PMID: 17682116.
      Citations: 1     Fields:    Translation:Humans
    48. Estes L, Orenstein R. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Ther. 2007 Feb; 29(2):381-3; author reply 383-4. PMID: 17472831.
      Citations: 2     Fields:    Translation:HumansCells
    49. Claassen DO, Batsis JA, Orenstein R. Proteus mirabilis: a rare cause of infectious endocarditis. Scand J Infect Dis. 2007; 39(4):373-5. PMID: 17454908.
      Citations: 3     Fields:    Translation:HumansCells
    50. Uslan DZ, Jacobson KM, Kumar N, Berbari EF, Orenstein R. A woman with fever and rash after African safari. Clin Infect Dis. 2006 Sep 01; 43(5):609, 661-2. PMID: 16897839.
      Citations:    Fields:    Translation:Humans
    51. Eid AJ, Orenstein R. Metabolic and morphologic complications of HIV infection. J Med Liban. 2006 Apr-Jun; 54(2):97-105. PMID: 17087001.
      Citations: 1     Fields:    Translation:Humans
    52. Bongartz T, Matteson EL, Orenstein R. Tumor necrosis factor antagonists and infections: the small print on the price tag. Arthritis Rheum. 2005 Oct 15; 53(5):631-5. PMID: 16208645.
      Citations: 1     Fields:    Translation:HumansAnimals
    53. Orenstein R. Travel in patients receiving TNF-alpha inhibitors. Travel Med Infect Dis. 2005 May; 3(2):105-9. PMID: 17292013.
      Citations: 3     Fields:    
    54. Orenstein R. Andrew Taylor Still and the Mayo brothers: convergence and collaboration in 21st-century osteopathic practice. J Am Osteopath Assoc. 2005 May; 105(5):251-4. PMID: 16027479.
      Citations:    Fields:    
    55. Orenstein R. Anti-interleukin-12 antibody for active Crohn's disease. N Engl J Med. 2005 Feb 10; 352(6):627-8; author reply 627-8. PMID: 15703432.
      Citations: 1     Fields:    Translation:Humans
    56. Prabhu RM, Orenstein R. Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis. Clin Infect Dis. 2004 Oct 15; 39(8):1253-4. PMID: 15486856.
      Citations: 13     Fields:    Translation:HumansAnimals
    57. Prabhu RM, Bonnell M, Currier BL, Orenstein R. Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis. 2004 Oct 01; 39(7):e74-7. PMID: 15472837.
      Citations: 12     Fields:    Translation:Humans
    58. Orenstein R, Tsogas N. Looking beyond highly active antiretroviral therapy: drug-related hepatotoxicity in patients with human immunodeficiency virus infection. Pharmacotherapy. 2002 Nov; 22(11):1468-78. PMID: 12432973.
      Citations: 2     Fields:    Translation:Humans
    59. Orenstein R. Presenting syndromes of human immunodeficiency virus. Mayo Clin Proc. 2002 Oct; 77(10):1093-102; quiz 1102. PMID: 12374253.
      Citations: 1     Fields:    Translation:Humans